Innate Pharma S.A. (ADR)
General ticker "IPHA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $161.1M (TTM average)
Innate Pharma S.A. (ADR) follows the US Stock Market performance with the rate: 2.7%.
Estimated limits based on current volatility of 2.2%: low 1.90$, high 1.99$
Factors to consider:
- Total employees count: 235 as of 2019
Short-term IPHA quotes
Long-term IPHA plot
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | €12.62MM |
| Operating Expenses | €64.20MM |
| Operating Income | €-51.58MM |
| Non-Operating Income | €2.10MM |
| Interest Expense | €0.57MM |
| R&D Expense | €51.98MM |
| Income(Loss) | €-49.47MM |
| Profit(Loss)* | €-49.47MM |
| Stockholders Equity | €8.83MM |
| Assets | €111.06MM |
| Operating Cash Flow | €-6.90MM |
| Capital expenditure | €0.39MM |
| Investing Cash Flow | €9.20MM |
| Financing Cash Flow | €-6.01MM |
| Earnings Per Share** | €-0.61 |
| Ordinary share to ADR | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.